Pharma Manufacturing Challenges
Pharmaceutical production operates under some of the most stringent regulatory environments in manufacturing. Every production record must be complete, accurate, and unalterable. Equipment must be qualified. Processes must be validated. And any deviation must be documented with a clear audit trail.
At the same time, pharma plants face the same operational pressures as any manufacturer: maximising output, minimising waste, and reducing downtime. OEE in pharmaceutical facilities typically ranges from 70–80% — lower than automotive (85–90%) mainly due to longer changeovers, CIP/SIP procedures, and regulatory hold times.
Regulatory Requirements
21 CFR Part 11 (FDA)
Electronic records must be trustworthy and equivalent to paper. Requires audit trails, access controls, time-stamped entries, and electronic signatures. Applies to all production data captured by MES.
EU GMP Annex 11
European equivalent of 21 CFR Part 11. Requires computerised system validation, backup/restore, data integrity, and change control for all production IT systems.
GMP / GxP Validation
All computerised systems used in GMP-regulated manufacturing must be validated (Computer System Validation — CSV). MES must demonstrate Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
Data Integrity (ALCOA+)
Production data must be Attributable, Legible, Contemporaneous, Original, Accurate — plus Complete, Consistent, Enduring, Available. MES must prevent unauthorised modification and provide full reconstruction of any production event.
OEE in Pharmaceutical Manufacturing
OEE analysis in pharma follows the same three components — Availability, Performance, Quality — but pharma-specific loss categories require careful classification:
- Availability losses: Unplanned breakdowns, changeover time (product/batch/format changes), CIP/SIP cleaning cycles (can be planned but often exceed target duration)
- Performance losses: Speed reductions due to process optimisation constraints, minor stops due to material feeding issues, label verification fails
- Quality losses: Batch rejection (out-of-specification), in-process sampling hold time, first-pass yield failures on packaging lines
Shopfloor Copilot classifies every downtime event against your custom reason code hierarchy — with separate categories for regulatory holds vs. maintenance-caused stops — ensuring clean OEE data that passes regulatory scrutiny.
How Shopfloor Copilot Supports Pharma Compliance
- On-premise deployment — No production data leaves your facility. Critical for FDA data sovereignty and EU GDPR manufacturing data requirements.
- Immutable audit log — Every OEE event, user action, and configuration change is time-stamped and cryptographically logged. Supports 21 CFR Part 11 audit trail requirements.
- Role-based access control — JWT-based authentication with role separation (operator, team leader, QA, admin). Only authorised users can acknowledge alarms or modify baselines.
- Electronic shift handover — Structured shift handover records that capture batch status, deviations, quality observations, and open actions — replacing uncontrolled paper logs.
- OPC UA connectivity — Connects to all major pharma automation platforms (Siemens, Rockwell, B&R, Beckhoff) without custom middleware.
Frequently Asked Questions
OEE and Compliance, Without Compromise
Deploy Shopfloor Copilot on your own infrastructure — fully air-gapped if required. Get real-time OEE visibility, 21 CFR Part 11-aligned audit trails, and structured digital shift handover — validated to your requirements.
Explore Platform →